We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Time-Restricted Eating vs Dietetic Guidance for Glycaemic Outcomes in Adults at Risk of Type 2 Diabetes

MedXY Editorial Team•Jun 17, 2026•Diabetes & Endocrinology
dietetic guidanceHbA1crandomized trialtime-restricted eatingType 2 diabetes prevention

Overview

Time-restricted eating (TRE) has gained attention as a simple way to improve metabolic health without requiring detailed calorie counting or major changes in food choice. In TRE, all daily food and drink calories are consumed within a fixed window, usually 6 to 10 hours, with fasting outside that window. This trial tested whether TRE is at least as effective as individualized dietetic guidance (IDG) for improving long-term blood sugar control in adults at risk of type 2 diabetes.

The main question was whether TRE could match a more traditional, dietitian-led approach in lowering HbA1c, a blood test that reflects average blood glucose over the previous 2 to 3 months. People with overweight or obesity and a high diabetes risk score were studied because they are more likely to progress to type 2 diabetes and may benefit from early lifestyle intervention.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Linking Female Infertility History to Type 2 Diabetes Risk: Insights from the Nurses’ Health Study IIThis study explores the increased risk of type 2 diabetes among women with a history of infertility, highlighting specific infertility causes and implications independent of BMI.Sep 6, 2026Time-Restricted Eating in Adults With Type 1 Diabetes: Safety and Glycemic Benefits Without Significant Weight LossA 6-month randomized controlled trial found that time-restricted eating (TRE) in adults with type 1 diabetes is safe and improves HbA1c levels but does not significantly reduce body weight compared to calorie restriction or no intervention.Aug 17, 2026Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose: A Synthesis of Clinical Evidence and Mechanistic InsightsThis review integrates recent randomized trial data with observational studies to clarify cannabis inhalation’s acute impact on cardiac ectopy, physical activity, sleep, and glucose, highlighting complex arrhythmia associations and clAug 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice
This study reveals significant HbA1c and glucose discrepancies, especially in Black individuals, and introduces a personalized HbA1c correction (pA1C) that enhances diabetes management across racial groups.
Aug 13, 2026
Levothyroxine in Pregnancy for Subclinical Hypothyroidism or Hypothyroxinemia: No Benefit on Child IQA randomized trial found that levothyroxine treatment for subclinical hypothyroidism or hypothyroxinemia starting between 8 and 20 weeks of gestation did not improve IQ scores in children at age 5 years compared with placebo.Aug 18, 2026
Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical OutcomesThis analysis of the SOUL trial shows oral semaglutide reduces major cardiovascular events, with greater benefits linked to higher baseline HbA1c and larger HbA1c reductions, while BMI changes did not significantly affect outcomes.Jul 22, 2026